Biosig Historical Income Statement
| BSGM Stock | USD 1.71 0.07 3.93% |
Historical analysis of Biosig Technologies income statement accounts such as Interest Expense of 2.6 K, Selling General Administrative of 19.1 M or Other Operating Expenses of 25.1 M can show how well Biosig Technologies performed in making a profits. Evaluating Biosig Technologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Biosig Technologies's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Biosig Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biosig Technologies is a good buy for the upcoming year.
Biosig |
About Biosig Income Statement Analysis
Biosig Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Biosig Technologies shareholders. The income statement also shows Biosig investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Biosig Technologies Income Statement Chart
Biosig Technologies Income Statement is one of the three primary financial statements used for reporting Biosig's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biosig Technologies revenue and expense. Biosig Technologies Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Biosig Technologies' Depreciation And Amortization is very stable compared to the past year. As of the 4th of May 2024, Research Development is likely to grow to about 5.9 M, while Selling General Administrative is likely to drop about 19.1 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Biosig Technologies. It is also known as Biosig Technologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Biosig Technologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Biosig Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.At this time, Biosig Technologies' Depreciation And Amortization is very stable compared to the past year. As of the 4th of May 2024, Research Development is likely to grow to about 5.9 M, while Selling General Administrative is likely to drop about 19.1 M.
| 2023 | 2024 (projected) | Extraordinary Items | 2.9M | 2.6M | Reconciled Depreciation | 361K | 232.6K |
Biosig Technologies income statement Correlations
Click cells to compare fundamentals
Biosig Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biosig Technologies income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 53.9K | 551K | (355K) | 293K | 361K | 379.1K | |
| Interest Expense | 132.8K | 45K | 2K | 3K | 2.7K | 2.6K | |
| Selling General Administrative | 24.8M | 41.0M | 27.9M | 21.4M | 23.1M | 19.1M | |
| Other Operating Expenses | 34.6M | 59.2M | 33.9M | 27.6M | 28.5M | 25.1M | |
| Operating Income | (34.6M) | (59.2M) | (33.4M) | (27.3M) | (28.5M) | (29.9M) | |
| Ebit | (34.6M) | (59.2M) | (33.4M) | (27.3M) | (28.5M) | (29.9M) | |
| Research Development | 9.7M | 18.1M | 5.6M | 5.8M | 5.1M | 5.9M | |
| Ebitda | (34.5M) | (58.6M) | (33.8M) | (27.0M) | (28.2M) | (29.6M) | |
| Total Operating Expenses | 34.6M | 59.2M | 33.7M | 27.5M | 28.5M | 25.1M | |
| Income Before Tax | (34.5M) | (59.1M) | (32.9M) | (27.3M) | (28.7M) | (30.1M) | |
| Total Other Income Expense Net | 133.2K | 44K | 555K | 3K | (187K) | (177.7K) | |
| Net Income | (33.9M) | (52.2M) | (31.4M) | (27.3M) | (29.0M) | (30.5M) | |
| Income Tax Expense | (549.1K) | (7.0M) | (1.5M) | 9K | 360K | 378K | |
| Gross Profit | (54.3K) | (550K) | 242K | 229K | (343K) | (325.9K) | |
| Preferred Stock And Other Adjustments | 119.9K | 884.7K | 25.2K | 14K | 12.6K | 12.0K | |
| Net Income From Continuing Ops | (34.5M) | (59.1M) | (32.9M) | (27.3M) | (28.7M) | (30.1M) | |
| Cost Of Revenue | 54.3K | 550K | 199K | 57K | 361K | 379.1K | |
| Net Income Applicable To Common Shares | (18.1M) | (34.1M) | (52.2M) | (31.9M) | (28.7M) | (30.2M) | |
| Interest Income | 132.8K | 45K | 2K | 3K | 9K | 8.6K | |
| Net Interest Income | 132.8K | 45K | 2K | 3K | 9K | 8.6K | |
| Reconciled Depreciation | 54.3K | 550K | 198K | 293K | 361K | 232.6K |
Pair Trading with Biosig Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biosig Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosig Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against Biosig Stock
| 0.83 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
| 0.76 | ENSG | Ensign Group | PairCorr |
| 0.73 | DOCS | Doximity Financial Report 21st of May 2024 | PairCorr |
| 0.69 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
| 0.58 | DH | Definitive Healthcare | PairCorr |
The ability to find closely correlated positions to Biosig Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biosig Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biosig Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biosig Technologies to buy it.
The correlation of Biosig Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biosig Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biosig Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biosig Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Biosig Stock analysis
When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.91) | Return On Assets (6.03) | Return On Equity (59.77) |
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.